Chemotherapy of Advanced Non-Small-Cell Lung Cancer
- 1 August 1989
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 12 (4), 345-349
- https://doi.org/10.1097/00000421-198908000-00014
Abstract
One hundred fifty-two patients with locally advanced or metastatic non-small-cell lung cancer were randomized to receive treatment with one of three cis-platin-containing chemotherapy regimens: vindesine/cis-platin, etoposide/cis-platin, or vindesine/etoposide/cis-platin. Following an 8-week induction course of treatment, patients were evaluated for response; responders continued to receive monthly chemotherapy. All patients were followed until death. Response rates for the three regimens were 10%, 6%, and 24%, respectively; the cis-platin/vindesine/etoposide regimen produced more responses than did either cis-platin/etoposide or cis- platin/vindesine (p < 0.05). However, median survival was not improved with the three-drug regimen, and myelosup- pression produced by this regimen was worse. The 20-week median survival for the entire group suggests that these treatments had no impact on survival. None of these regimens can be recommended for routine treatment of patients with advanced non-small-cell lung cancer. The addition of vin- desine did not make a significant impact in response rate or overall survival in this study.This publication has 8 references indexed in Scilit:
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- COMBINATION CHEMOTHERAPY WITH VINDESINE, ETOPOSIDE, AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER - A PILOT-STUDY OF THE SOUTHEASTERN-CANCER-STUDY-GROUP1986
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1985
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981
- PHASE-II EVALUATION OF VINDESINE IN PATIENTS WITH NON-SMALL CELL-CARCINOMA OF THE LUNG1979